Miriam Scadeng
University of Auckland · 181 works · 5,850 citations · h-index 36
Top works
- JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity
- Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
- Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival
- Development of a novel mouse glioma model using lentiviral vectors
- Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance
- Maintenance of Metabolic Homeostasis by Sestrin2 and Sestrin3
- Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ Activity and Insulin Sensitivity
- Cortical depth-specific microvascular dilation underlies laminar differences in blood oxygenation level-dependent functional MRI signal
- Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
- Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer
- Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma
- The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice
- Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings
- Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
- Functional imaging of dolphin brain metabolism and blood flow
- Enhanced Magnetic Resonance Contrast of Fe3O4 Nanoparticles Trapped in a Porous Silicon Nanoparticle Host
- A murine model of inflammation-induced cerebral microbleeds
- G protein–coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice
- Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging
- Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma